MX2012004348A - Uso de la combinacion de teriflunomida y acetato de glatiramer para tratar la esclerosis multiple. - Google Patents

Uso de la combinacion de teriflunomida y acetato de glatiramer para tratar la esclerosis multiple.

Info

Publication number
MX2012004348A
MX2012004348A MX2012004348A MX2012004348A MX2012004348A MX 2012004348 A MX2012004348 A MX 2012004348A MX 2012004348 A MX2012004348 A MX 2012004348A MX 2012004348 A MX2012004348 A MX 2012004348A MX 2012004348 A MX2012004348 A MX 2012004348A
Authority
MX
Mexico
Prior art keywords
teriflunomide
combination
multiple sclerosis
glatiramer acetate
treating multiple
Prior art date
Application number
MX2012004348A
Other languages
English (en)
Inventor
Patrice Douillet
Gerald Frangin
William Byrnes
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09305999A external-priority patent/EP2314291A1/en
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of MX2012004348A publication Critical patent/MX2012004348A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Esta invención se refiere al uso de la combinación de teriflunomida o una de sus sales farmacéuticamente aceptables y acetato de glatiramer para tratar la esclerosis múltiple.
MX2012004348A 2009-10-22 2010-10-13 Uso de la combinacion de teriflunomida y acetato de glatiramer para tratar la esclerosis multiple. MX2012004348A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09305999A EP2314291A1 (en) 2009-10-22 2009-10-22 Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis
EP09306036 2009-10-29
US26195409P 2009-11-17 2009-11-17
US28615309P 2009-12-14 2009-12-14
PCT/US2010/052423 WO2011049792A1 (en) 2009-10-22 2010-10-13 Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
MX2012004348A true MX2012004348A (es) 2012-05-22

Family

ID=43448090

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004348A MX2012004348A (es) 2009-10-22 2010-10-13 Uso de la combinacion de teriflunomida y acetato de glatiramer para tratar la esclerosis multiple.

Country Status (12)

Country Link
US (1) US20120244106A1 (es)
EP (1) EP2470269A1 (es)
JP (1) JP2013508372A (es)
KR (1) KR20120089295A (es)
CN (1) CN102655910A (es)
AU (1) AU2010308364A1 (es)
BR (1) BR112012009220A2 (es)
CA (1) CA2778256A1 (es)
IL (1) IL219212A0 (es)
MX (1) MX2012004348A (es)
RU (1) RU2012120870A (es)
WO (1) WO2011049792A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
WO2007081975A2 (en) * 2006-01-11 2007-07-19 Teva Pharmaceutical Industries, Ltd. Method of treating multiple sclerosis

Also Published As

Publication number Publication date
RU2012120870A (ru) 2013-11-27
JP2013508372A (ja) 2013-03-07
US20120244106A1 (en) 2012-09-27
WO2011049792A1 (en) 2011-04-28
CA2778256A1 (en) 2011-04-28
KR20120089295A (ko) 2012-08-09
BR112012009220A2 (pt) 2016-11-22
IL219212A0 (en) 2012-06-28
CN102655910A (zh) 2012-09-05
AU2010308364A1 (en) 2012-05-03
EP2470269A1 (en) 2012-07-04

Similar Documents

Publication Publication Date Title
IL252699A0 (en) Use of lequinimod to treat multiple sclerosis
ZA201204625B (en) Analogues for the treatment or prevention of flavivirus infections
TN2012000458A1 (en) Uses of dgat1 inhibitors
MX2012009748A (es) USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL.
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
IL226049A0 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
PH12012501492B1 (en) Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
UA105556C2 (uk) Комбінація сполук, що містить інгібітори віл інтегрази з іншими терапевтичними агентами
PL3378862T3 (pl) Dihydropirymidynoizochinolinony i ich kompozycie farmaceutyczne do leczenia stwardnienia rozsianego
IL193846A (en) Use of a n-terminal peptide that has been re-regulated to produce a drug to treat inflammatory conditions
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
MY152279A (en) Immediate release pharmaceutical compositions comprising oxycodone and naloxone
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
ZA201208646B (en) Pharmaceutical combination for the treatment of pain
MX360030B (es) Metodos para tratar el trastorno bipolar.
NZ706740A (en) Use of vap-1 inhibitors for treating fibrotic conditions
MY172807A (en) Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder
IL213703A (en) Compounds for the treatment of pain and other diseases
PH12013500077A1 (en) Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
MX2015007945A (es) Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.
EP3449917A3 (en) Tapentadol for preventing chronification of pain
MX2012004348A (es) Uso de la combinacion de teriflunomida y acetato de glatiramer para tratar la esclerosis multiple.
EP2220057A4 (en) PROSTAGLANDIN E1 AND E2 ANALOGUES FOR THE TREATMENT OF VARIOUS MEDICAL CONDITIONS
EP2274042A4 (en) TREATMENT AND / OR PREVENTION OF MULTIPLE SCLEROSIS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal